HOME >> MEDICINE >> NEWS
Proteome Systems signs agreement with Prince Henry's Institute for Ovarian Cancer Diagnostic Test

Sydney, Australia: Proteome Systems (ASX:PXL) today announced a collaboration with Prince Henry's Institute Medical Research (PHIMR) to combine their IP and expertise in ovarian cancer for the discovery and development of novel diagnostic markers.
  • If ovarian cancer is detected early there is a very good prognosis for full recovery. Currently, there is no test for early detection of ovarian cancer.
  • PXL has patented several protein and carbohydrate candidate markers for the development of an ovarian cancer diagnostic test.
  • Melbourne-based PHIMR has previously developed a test to detect ovarian cancer in post-menopausal woman, a significant sector of the target population.

Of all the gynaecologic cancers, ovarian malignancies represent the greatest clinical challenge. Around 1 in 56 women will develop ovarian cancer during their lifetime. Due to the absence of clear symptoms, ovarian cancer is usually detected when it has already spread beyond the ovary. At this relatively late stage the 5 year survival rate has decreased to ~30% while if the cancer is detected when confined to the ovary, the corresponding 5-year survival rate is >85%. This has led to the need to develop markers that can detect ovarian cancer at this early stage.

Proteome Systems has discovered and patented novel markers for epithelial ovarian cancer using its proprietary proteomic and glycoproteomic technology platforms. The company is actively seeking partnerships with academic and clinical groups with expertise in ovarian cancer to further expand its portfolio of ovarian cancer markers and clinically evaluate these for the development of a diagnostic test.

Associate Professor David Robertson leads the team at PHIMR that has previously developed a test to diagnose ovarian cancer (Robertson et al., 2002; Robertson and Oehler, 2005). The test is useful for initial diagnosis and monitoring recurrence of the disease in post-menopausal women, but i
'"/>

Contact: Jenny Harry
61-2-8877-8947
Research Australia
12-Oct-2005


Page: 1 2

Related medicine news :

1. Proteome Systems Ltd and US-based Egenix Inc to develop semen-based test for prostate cancer
2. Proteome Systems raises $10m through a private placement to institutional and professional investors
3. Ossur v. Bledsoe Brace Systems
4. Pot bellies linked to early signs of cardiovascular disease
5. Heading to Siberia: UH signs agreement with Russian Academy of Sciences
6. Most young women dont recognize heart attack warning signs
7. Mice with a migraine show signs of brain damage
8. New cigarette designs dont offer lower predicted cancer risks
9. USP signs Memorandum of Understanding with the Pharmaceutical Export Promotion Council
10. Noise-immune stethoscope helps medics hear vital signs in loud environments
11. Before dementias first signs appear, weight-loss rate doubles in elderly

Post Your Comments:
(Date:4/17/2014)... that as many as 10 million older Americans suffer ... and isolation. , However, new research a project ... Americans for six years found that Internet use ... by more than 30 percent. , "That,s a very ... professor of telecommunication, information studies and media who led ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... Boston University School of Medicine (BUSM) have discovered ... in an experimental model. The findings, reported in ... Abuse , may lead to more effective treatments ... one of the leading causes of illness and ... economic impact by limiting the productivity of workers ...
(Date:4/17/2014)... led by researchers at UC Davis has shown that ... role in cell division, also boosts the mitochondrial activity ... the complex has been shown to perform both jobs. ... target to control cellular energy production, potentially advancing cancer ... today in the journal Developmental Cell . , ...
(Date:4/17/2014)... Cesar A. Arias, M.D., Ph.D., at The University of ... a new superbug that caused a bloodstream infection in ... 17 issue of The New England Journal of ... a class of highly-resistant bacteria known as methicillin-resistant ... cause of hospital and community-associated infections. The superbug has ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ... agreement with Hitachi Koki of Japan ... North America . NuAire will utilize its network ... and Canada to offer assistance in application ...
(Date:1/14/2014)... New York , January 14, 2014 ... Closed System Transfer Devices (CSTD) for hazardous drugs, today announced ... for the fourth straight year.   ... for pharmacy technicians, pharmacists, nurses and other medical ...
Breaking Medicine Technology:Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Equashield's Sales Grow by 60% in 2013 2
Cached News: